ConductScience.org, home

Paper20162282

Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt.

Chikamori F and 5 others. World J Surg, 2010. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt. Papers, record 20162282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20162282

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt.
PubMed
Journal
World J Surg
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2021-10-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chikamori FFumio
2Inoue AAtsushi
3Okamoto HHiroshi
4Kuniyoshi NNobutoshi
5Kawashima TTakahiko
6Takase YYasuhiro

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Embolization, TherapeuticMajor topic
Esophageal and Gastric VaricesMajor topic
Portal SystemMajor topic
Aged
Combined Modality Therapy
Female
Hemodynamics
Humans
Liver Cirrhosis
Male
Middle Aged
Portasystemic Shunt, Surgical
Splenic Artery

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112143250Bleeding portal-hypertensive gastropathy managed successfully by partial splenic embolization.Hepatogastroenterology2002https://conductscience.org/library/papers/12143250PubMed
211283531Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts.Surgery2001https://conductscience.org/library/papers/11283531PubMed
311464006Correlation between endoscopic and angiographic findings in patients with esophageal and isolated gastric varices.Dig Surg2001https://conductscience.org/library/papers/11464006PubMed
46016965Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations.Surgery1967https://conductscience.org/library/papers/6016965PubMed
515269027TIPS versus transcatheter sclerotherapy for gastric varices.AJR Am J Roentgenol2004https://conductscience.org/library/papers/15269027PubMed
611053938Short-term hemodynamic effects of transjugular retrograde obliteration of gastric varices with gastrorenal shunt.Dig Surg2000https://conductscience.org/library/papers/11053938PubMed
78672742Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.J Gastroenterol Hepatol1996https://conductscience.org/library/papers/8672742PubMed
88661570Transjugular retrograde obliteration for gastric varices.Abdom Imaging1996https://conductscience.org/library/papers/8661570PubMed
920012612Effect of liver transplantation on spleen size, collateral veins, and platelet counts.World J Surg2010https://conductscience.org/library/papers/20012612PubMed
103391371Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization.Gastroenterology1988https://conductscience.org/library/papers/3391371PubMed
11528164Embolization of the spleen for treatment of splenomegaly and hypersplenism in patients with portal hypertension.Invest Radiol1979https://conductscience.org/library/papers/528164PubMed
1212607123Partial splenic embolization: long-term outcome.Langenbecks Arch Surg2003https://conductscience.org/library/papers/12607123PubMed
1318647931Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization.AJR Am J Roentgenol2008https://conductscience.org/library/papers/18647931PubMed
142365213Endoscopic classification of gastric varices.Gastrointest Endosc1990https://conductscience.org/library/papers/2365213PubMed
158908553Long term follow-up for patients with liver cirrhosis after partial splenic embolization.Hepatogastroenterology1996https://conductscience.org/library/papers/8908553PubMed
1618019732Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism.Hepatogastroenterology2007https://conductscience.org/library/papers/18019732PubMed
1712397733A comparison of combination endoscopic therapy and interventional radiology with esophageal transection for the treatment of esophageal varices.Hepatogastroenterology2002https://conductscience.org/library/papers/12397733PubMed
1812239963Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis.Hepatogastroenterology2002https://conductscience.org/library/papers/12239963PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
37520392Antecubital vein approach of retrograde transvenous obliteration using a steerable triaxial system for portosystemic encephalopathy.Radiol Case Rep2023https://conductscience.org/library/papers/37520392PubMed
35208529Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.Medicina (Kaunas)2022https://conductscience.org/library/papers/35208529PubMed
34711891Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension.Sci Rep2021https://conductscience.org/library/papers/34711891PubMed
30796573Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding.Eur Radiol2019https://conductscience.org/library/papers/30796573PubMed
28299974Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.Exp Biol Med (Maywood)2017https://conductscience.org/library/papers/28299974PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20162282

GET https://conductscience.org/api/papers/v1/20162282/authors